Cargando…
P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621510/ http://dx.doi.org/10.1097/01.HS9.0000891024.63916.91 |
| _version_ | 1784821573054627840 |
|---|---|
| author | Vassilakopoulos, Theodoros P. Liaskas, Athanasios Rizzuto, Giuliana Symeonidis, Argyrios Palma, Marzia Angelopoulou, Maria K. Giatra, Chara Kondopidou, Flora Dimou, Maria Musseti, Alberto Xagoraris, Ioanna Siakantaris, Marina Verigou, Evgenia Panitsas, Fotios Asimakopoulos, John Arapaki, Maria Chatzidimitriou, Chrysovalantou Belia, Marina Sachanas, Sotirios Korkolopoulou, Penelope Cabras, Antonello Variamis, Eleni Panayiotidis, Panayiotis Bakiri, Maria Karmiris, Themistoklis Rassidakis, Georgios Z. Corradini, Paolo Pangalis, Gerassimos Viviani, Simonetta |
| author_facet | Vassilakopoulos, Theodoros P. Liaskas, Athanasios Rizzuto, Giuliana Symeonidis, Argyrios Palma, Marzia Angelopoulou, Maria K. Giatra, Chara Kondopidou, Flora Dimou, Maria Musseti, Alberto Xagoraris, Ioanna Siakantaris, Marina Verigou, Evgenia Panitsas, Fotios Asimakopoulos, John Arapaki, Maria Chatzidimitriou, Chrysovalantou Belia, Marina Sachanas, Sotirios Korkolopoulou, Penelope Cabras, Antonello Variamis, Eleni Panayiotidis, Panayiotis Bakiri, Maria Karmiris, Themistoklis Rassidakis, Georgios Z. Corradini, Paolo Pangalis, Gerassimos Viviani, Simonetta |
| author_sort | Vassilakopoulos, Theodoros P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621510 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96215102022-11-01 P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome Vassilakopoulos, Theodoros P. Liaskas, Athanasios Rizzuto, Giuliana Symeonidis, Argyrios Palma, Marzia Angelopoulou, Maria K. Giatra, Chara Kondopidou, Flora Dimou, Maria Musseti, Alberto Xagoraris, Ioanna Siakantaris, Marina Verigou, Evgenia Panitsas, Fotios Asimakopoulos, John Arapaki, Maria Chatzidimitriou, Chrysovalantou Belia, Marina Sachanas, Sotirios Korkolopoulou, Penelope Cabras, Antonello Variamis, Eleni Panayiotidis, Panayiotis Bakiri, Maria Karmiris, Themistoklis Rassidakis, Georgios Z. Corradini, Paolo Pangalis, Gerassimos Viviani, Simonetta Hemasphere Relapsed/Refractory Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621510/ http://dx.doi.org/10.1097/01.HS9.0000891024.63916.91 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Relapsed/Refractory Vassilakopoulos, Theodoros P. Liaskas, Athanasios Rizzuto, Giuliana Symeonidis, Argyrios Palma, Marzia Angelopoulou, Maria K. Giatra, Chara Kondopidou, Flora Dimou, Maria Musseti, Alberto Xagoraris, Ioanna Siakantaris, Marina Verigou, Evgenia Panitsas, Fotios Asimakopoulos, John Arapaki, Maria Chatzidimitriou, Chrysovalantou Belia, Marina Sachanas, Sotirios Korkolopoulou, Penelope Cabras, Antonello Variamis, Eleni Panayiotidis, Panayiotis Bakiri, Maria Karmiris, Themistoklis Rassidakis, Georgios Z. Corradini, Paolo Pangalis, Gerassimos Viviani, Simonetta P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome |
| title | P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome |
| title_full | P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome |
| title_fullStr | P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome |
| title_full_unstemmed | P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome |
| title_short | P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome |
| title_sort | p114: very late relapses in patients with hodgkin lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: treatment strategies and prognostic factors for the outcome |
| topic | Relapsed/Refractory |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621510/ http://dx.doi.org/10.1097/01.HS9.0000891024.63916.91 |
| work_keys_str_mv | AT vassilakopoulostheodorosp p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT liaskasathanasios p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT rizzutogiuliana p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT symeonidisargyrios p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT palmamarzia p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT angelopouloumariak p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT giatrachara p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT kondopidouflora p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT dimoumaria p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT mussetialberto p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT xagorarisioanna p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT siakantarismarina p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT verigouevgenia p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT panitsasfotios p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT asimakopoulosjohn p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT arapakimaria p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT chatzidimitriouchrysovalantou p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT beliamarina p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT sachanassotirios p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT korkolopouloupenelope p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT cabrasantonello p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT variamiseleni p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT panayiotidispanayiotis p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT bakirimaria p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT karmiristhemistoklis p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT rassidakisgeorgiosz p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT corradinipaolo p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT pangalisgerassimos p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome AT vivianisimonetta p114verylaterelapsesinpatientswithhodgkinlymphomaoccuring5yearsafterinitialtreamentwithchemotherapyradiotherapytreatmentstrategiesandprognosticfactorsfortheoutcome |